http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019175401-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7b9a49737980e25e980bd676bd5f9c1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00772
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0079
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 2019-02-11^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac0cd47aafda06c61218dd36233bd8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9f8ed31c80d890ea53a7e5d0de34729
publicationDate 2019-06-13^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019175401-A1
titleOfInvention Methods for treating eye conditions
abstract Architectures and techniques for treating conditions of the eye, such as meibomian gland disease, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement manipulations on tissue surrounding the orbit. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the meibomian gland, to treat meibomian gland disease. The treatments can affect at least one property of the eye and allow the liquifactions to flow more freely.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701202-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022013435-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D997355-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684421-B2
priorityDate 2011-09-08^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID964
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61872
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UT41
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130922
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5HKP6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ93MW7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9L7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA8WGN9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41773
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1771
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID966
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577455
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2384
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M1X5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59952
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VG48
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55EU1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600808
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID53175
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04635
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID53175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23980
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544408
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U780
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1769
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26504

Showing number of triples: 1 to 55 of 55.